Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
01.13.21
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business Update
01.05.21
OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia
12.17.20
Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract Infections

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events